Abstract
Objective
To describe the frequency, characteristics, location, pain intensity in breast cancer patients using the chemotherapy medication Docetaxel.
Methods
Longitudinal study involving 17 women with breast cancer under treatment using Docetaxel. The patients’ pain was assessed during three chemotherapy cycles, using the tools McGill Pain Questionnaire (Br-MPQ) and the Brief Pain Inventory (BPI). Spearman’s correlation and the Mann-Whitney test were used.
Results
The mean pain score increased in all variables of the BPI. When comparing the total coefficients on the Pain Assessment Index, 0.20; 0.33 and 0.24 were found in the first, second and third assessment, showing a correlation between the pain intensity and the interference in all daily activities on the BPI for the second assessment.
Conclusion
The occurrence of pain increased, compromising the participating women’s activities of daily living.
Breast neoplasms/drug therapy; Pain/etiology; Pain/chemically induced; Antineoplastic agents/adverse effects; Pain measurement